您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:瑞思迈:2024年度报告 - 发现报告

瑞思迈:2024年度报告

2025-08-08-美股财报爱***
AI智能总结
查看更多
瑞思迈:2024年度报告

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549___________________________________________________________________________________________ FORM10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year endedJune30, 2025 Commission file number:001-15317___________________________________________________________________________________________ ResMed Inc. (Exact name of registrant as specified in its charter)___________________________________________________________________________________________ Delaware(State or other jurisdiction of incorporation or organization)98-0152841(IRS Employer Identification No.)9001 Spectrum Center Blvd.San Diego,CA92123United Statesof America(Address of principal executive offices, including zip code)(858)836-5000(Registrant’s telephone number, including area code)Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.YesxNo¨ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes¨Nox Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90days.YesxNo¨ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).YesxNo¨ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growthcompany. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of theExchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control overfinancial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.x If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect thecorrection of an error to previously issued financial statements.¨ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of theregistrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).¨ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes¨Nox $33,419,694,564. All directors, executive officers, and 10% stockholders of registrant are considered affiliates. This determination of affiliate status with respect to theforegoing calculation is not a determination for other purposes. At August4, 2025, the registrant had146,414,839shares of Common Stock, $0.004 par value, issued and outstanding. This number excludes 43,925,747 shares held bythe registrant as treasury shares. Portions of the registrant’s definitive Proxy Statement to be delivered to stockholders in connection with the registrant’s 2025 Annual Meeting of Stockholders, to befiled within 120 days after the end of the fiscal year covered by this Form 10-K, are incorporated by reference into Part III of this report. TABLE OF CONTENTS Cautionary Note Regarding Forward-Looking Statements1Part IItem 1Business1Item 1ARisk Factors25Item 1BUnresolved Staff Comments48Item 1CCybersecurity48Item 2Properties49Item 3Legal Proceedings50Item 4Mine Safety Disclosures50Part IIItem 5Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases ofEquity Securities51Item 6Selected Financial Data52Item 7Management’s Discussion and Analysis of Financial Condition and Results of Operations54Item 7AQuantitative and Qualitative Disclosures About Market and Business Risks66Item 8Consolidated Financial Statements and Supplementary Data69Item 9Changes in and Disagreements with Accountants on Accounting and Financial Disclosure104Item 9AControls and Procedures104Item 9BOther Information107It